Anna Protopapas
Chairman bei NUVALENT, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Anna Protopapas is currently the Independent Chairman at Nuvalent, Inc. since 2022 and the Director at Mersana Therapeutics, Inc. since 2015.
Previously, she served as the President & Chief Executive Officer at Millennium Pharmaceuticals, Inc. from 2013 to 2014.
She also held positions as an Independent Director at ARIAD Pharmaceuticals, Inc. from 2015 to 2017, a Director at Bioverativ, Inc. from 2017 to 2018, and as the Executive VP-Global Business Development at Takeda Pharmaceutical Co., Ltd.
from 2010 to 2014.
Additionally, she was the Head-Global Business Development at Takeda Pharmaceuticals International, Inc. from 2010 to 2014.
Ms. Protopapas has also served as a Director at Ensemble Therapeutics Corp.
and as an Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021.
She holds a graduate degree from the Massachusetts Institute of Technology, an undergraduate degree from Princeton University, and an MBA from Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.01.2024 | 437 660 ( 0,36% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Anna Protopapas
| Unternehmen | Position | Beginn |
|---|---|---|
| MERSANA THERAPEUTICS, INC. | Director/Board Member | 02.03.2015 |
| NUVALENT, INC. | Chairman | 30.03.2022 |
Ehemalige bekannte Positionen von Anna Protopapas
| Unternehmen | Position | Ende |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Director/Board Member | 03.06.2021 |
| BIOVERATIV INC | Director/Board Member | 08.03.2018 |
| ARIAD PHARMACEUTICALS, INC. | Director/Board Member | 16.01.2017 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Executive Officer | 01.10.2014 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The private company is based in Deerfield, IL. | Corporate Officer/Principal | 01.10.2014 |
Ausbildung von Anna Protopapas
| Massachusetts Institute of Technology | Graduate Degree |
| Princeton University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| NUVALENT, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The private company is based in Deerfield, IL. | Commercial Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
